bpc-157 liver (Body Protection Compound) | Research Peptide What to Know About Peptides

Rather than waiting for symptoms of cognitive decline to appear and then attempting to reverse established damage, some researchers advocate for early intervention with neuroprotective peptides in at-risk populations

Post-infection gut dysbiosis drives systemic inflammation, leaky gut, and immune dysregulation all of which amplify fatigue, cognitive impairment, and mood instability.3 BPC-157 has been shown in multiple animal studies to: Accelerate healing of the intestinal epithelium4 Reduce gut inflammation and restore tight junction integrity5 Modulate the vagus nerve, which connects gut function to brain and immune signaling6 For long COVID patients dealing with GI symptoms, food intolerances, or fatigue that tracks with gut dysfunction, this mechanism is directly relevant

Possible interactions of the peptide with serotonin and thus its antidepressant effects are also being studied

Compared with the placebo control group, EH301 can significantly alleviate the development of ALS